NEW YORK (GenomeWeb News) – Molecular dermatology company PharmaGenoma said today that it has signed up Svenson Haar Studios to distribute its HairDx subsidiary’s genetic test to predict the likelihood of a common type of hair loss.

Svenson will distribute the HairDx test, which provides a gene-based analysis of the chances that men and women will develop androgenetic alopecia, through a network of 17 centers throughout Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.